375 A Phase 1 dose escalation study of the oral heat shock protein 90 (Hsp90) inhibitor PF-04929113/SNX-5422 (PF-113) and its associated ocular toxicity
Infante, J, Weiss, G, Jones, S, Tibes, R, Bendell, J, Brega, N, Torti, V, Hoff, D. Von, III, H. Burris, Ramanathan, R
Published in European journal of cancer supplements (01.11.2010)
Published in European journal of cancer supplements (01.11.2010)
Get full text
Journal Article
Abstract P6-17-35: Withdrawn
Hamilton, EP, Barve, M, Bardia, A, Beeram, M, Edenfield, WJ, Noonan, A, Tolcher, A, Bendell, J, Mosher, R, Xu, J, Hailman, E, Burris III, H, Soliman, HH
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P3-14-05: Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with metastatic breast cancer
Forero, A, Burris III, H, Mita, M, Specht, J, Weise, A, Liu, MC, Modi, S, Pusztai, L, Kostic, A, Yang, J, Li, M, Hengel, S, Miller, K
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
Tan, A R, Dowlati, A, Stein, M N, Jones, S F, Infante, J R, Bendell, J, Kane, M P, Levinson, K T, Suttle, A B, Burris III, H A
Published in British journal of cancer (27.05.2014)
Published in British journal of cancer (27.05.2014)
Get full text
Journal Article
Abstract P1-01-16: Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelectorTM platform
Hamilton, EP, Yardley, DA, Burris III, HA, Shastry, M, Huynh, L, Bhikha, L, Singh, VM
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P1-14-06: A phase II randomized study with eribulin/cyclophosphamide (ErC) and docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in HER2-negative breast cancer- Final analysis of primary endpoint and correlative analysis results
Yardley, DA, Chandra, P, Hart, L, Wright, GS, Ward, P, Mani, A, Shastry, M, Finney, L, Guo, S, DeBusk, LM, Hainsworth, JD, Burris III, HA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]
Wu, Huali, Infante, Jeffrey, Keedy, Vicki, Jones, Suzanne, Chan, Emily, Bendell, Johanna, Lee, Wooin, Caron, Whitney, Zamboni, Beth, Ikeda, Satoshi, Kodaira, Hiroshi, Rothenberg, Mace, Burris III, Howard, Zamboni, William
Published in International journal of nanomedicine (01.07.2019)
Published in International journal of nanomedicine (01.07.2019)
Get full text
Journal Article
Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)
Yardley, DA, Peacock, N, Shroff, S, Molthrop, DC, Anz, B, Daniel, BR, Young, RR, Weaver, R, Harwin, W, Webb, CD, Ward, P, Shastry, M, DeBusk, LM, Midha, R, Hainsworth, JD, Burris III, HA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
A phase 1 study of weekly, divided dose perifosine in patients (pts) with non-small cell lung cancer (NSCLC)
Henderson, I. C., Spigel, D. R., Nemunaitis, J. J., Richards, D. A., Liebmann, J. E., Purcell, W. T., Birch, R., Gardner, L. R., Burris III, H. A.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Safety and pharmacokinetics (PK) of AMG 706, panitumumab, and gemcitabine/cisplatin (GC) for the treatment of advanced solid malignancies
Crawford, J., Burris III, H. A., Stein, M., Stephenson, J., Gilbert, J., Underwood, S., Sun, Y., Yang, L., Wiezorek, J., Schwartzberg, L. S.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Phase II pilot trial of imatinib mesylate with weekly docetaxel in metastatic breast cancer
Barton, J. H., Liggett, W., Mainwaring, M., Hainsworth, J. D., Simons, L., Spigel, D. R., Burris III, H. A., Yardley, D. A.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial
Yardley, DA, Peacock, NW, Hainsworth, JD, Burris, III HA
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
Wu, Huali, Infante, Jeffrey R, Keedy, Vicki L, Jones, Suzanne F, Chan, Emily, Bendell, Johanna C, Lee, Wooin, Kirschbrown, Whitney P, Zamboni, Beth A, Ikeda, Satoshi, Kodaira, Hiroshi, Rothenberg, Mace L, Burris, 3rd, Howard A, Zamboni, William C
Published in International journal of nanomedicine (01.01.2015)
Published in International journal of nanomedicine (01.01.2015)
Get full text
Journal Article
Abstract P3-14-06: Pharmacokinetic (PK) Interaction Potential of Trastuzumab-DM1 (T-DM1) and Pertuzumab (P) in Pts with HER2-Positive, Locally Advanced or MBC: Results from a Phase 1b/2 Study
Burris III, HA, Lu, D, Dees, EC, Cortes, J, Yi, J-H, Shih, T, Girish, S.
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article
P5-13-09: Correlation of Oncotype DX Recurrence Scores with Pathologic Response Following Neoadjuvant Ixabepilone and Cyclophosphamide in Patients with HER2−Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial
Yardley, DA, Peacock, NW, Hendricks, C, Huh, SY, Ketchum, S, Chao, C, Yoshizawa, C, Burris, III HA, Hainsworth, JD
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
P3-16-01: Safety Profile and Clinical Activity of Single-Agent BKM120, a Pan-Class I PI3K Inhibitor, for the Treatment of Patients with Metastatic Breast Carcinoma
Rodon, J, Bendell, JC, Abdul, Razak AR, Homji, N, Trandafir, L, Quadt, C, Graña-Suárez, B, Siu, LL, Di Tomaso, E, Demanse, D, Massacesi, C, Hirawat, S, Burris, III HA, Baselga, J
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer
Schilsky, R. L., Bukowski, R., Burris, H., Hochster, H., O'Rourke, M., Wall, J. G., Mani, S., Bonny, T., Levin, J., Hohneker, J.
Published in Annals of oncology (01.04.2000)
Published in Annals of oncology (01.04.2000)
Get full text
Journal Article
‘Tomudex’ (ZD1694): A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours
Cunningham, D., Zalcberg, J., Smith, I., Gore, M., Pazdur, R., Burris, H., Meropol, N. J., Kennealey, G., Seymour, L.
Published in Annals of oncology (01.02.1996)
Published in Annals of oncology (01.02.1996)
Get full text
Journal Article
Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
Greco, F. A., Erland, J. B., Morrissey, L. H., Burris, H. A., Hermann, R. C., Steis, R., Thompson, D., Gray, J., Hainsworth, J. D.
Published in Annals of oncology (01.02.2000)
Published in Annals of oncology (01.02.2000)
Get full text
Journal Article
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule
Brown, T D, O'Rourke, T J, Kuhn, J G, Craig, J B, Havlin, K, Burris, 3rd, H A, Cagnola, J, Hamilton, J M, Grindey, G B, Satterlee, W G
Published in Anti-cancer drugs (01.04.1994)
Published in Anti-cancer drugs (01.04.1994)
Get more information
Journal Article